CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation

[1]  T. de Baère,et al.  Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis , 2021, CardioVascular and Interventional Radiology.

[2]  O. V. van Delden,et al.  CIRSE Standards of Practice on Peri-operative Anticoagulation Management During Interventional Radiology Procedures , 2021, CardioVascular and Interventional Radiology.

[3]  P. Pereira,et al.  The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis , 2020, CardioVascular and Interventional Radiology.

[4]  Michael J. Lee,et al.  CIRSE Standards of Practice on Analgesia and Sedation for Interventional Radiology in Adults , 2020, CardioVascular and Interventional Radiology.

[5]  B. Hamm,et al.  Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma , 2020, Acta radiologica.

[6]  P. Pereira,et al.  Transarterial chemoembolisation of colorectal liver metastases with irinotecan-loaded beads: What every interventional radiologist should know , 2020, European journal of radiology open.

[7]  K. Malagari,et al.  Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography , 2020, CardioVascular and Interventional Radiology.

[8]  M. Falconi,et al.  Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Zi-Shu Zhang,et al.  Determination of Risk Factors for Pain After Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma , 2020, Journal of pain research.

[10]  ZiYu Qu,et al.  Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review , 2020, PloS one.

[11]  C. Catalano,et al.  Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure. , 2019, European journal of radiology.

[12]  M. Kudo,et al.  Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial , 2019, Gut.

[13]  T. Mazard,et al.  RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study , 2019, Cancer Imaging.

[14]  T. Albrecht,et al.  Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy , 2019, CardioVascular and Interventional Radiology.

[15]  N. Personeni,et al.  Role of liver biopsy in hepatocellular carcinoma , 2019, World journal of gastroenterology.

[16]  T. Luedde,et al.  Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study , 2019, CardioVascular and Interventional Radiology.

[17]  C. Catalano,et al.  Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE , 2019, La radiologia medica.

[18]  H. Reeves,et al.  Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead , 2019, CardioVascular and Interventional Radiology.

[19]  A. Lloyd,et al.  Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  E. Aksungur,et al.  Super-Selective Transarterial Chemoembolization with Doxorubicin-Loaded Drug-Eluting Beads Sized Below and Above 100 Microns in Hepatocellular Carcinoma: A Comparative Study , 2019, Journal of the Belgian Society of Radiology.

[21]  A. Gunn,et al.  Survival Outcomes of Very Small Drug-Eluting Beads Used in Chemoembolization of Unresectable Hepatocellular Carcinoma. , 2019, Journal of vascular and interventional radiology : JVIR.

[22]  S. Young,et al.  Current Trends in the Treatment of Hepatocellular Carcinoma with Transarterial Embolization: Variability in Technical Aspects , 2019, CardioVascular and Interventional Radiology.

[23]  Hui Zhang,et al.  Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study. , 2019, Journal of hepatology.

[24]  O. Chevallier,et al.  Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial. , 2019, Radiology.

[25]  C. Catalano,et al.  Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results , 2019, CardioVascular and Interventional Radiology.

[26]  O. Abdel-Rahman.  Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials , 2019, Clinical colorectal cancer.

[27]  Rahul S. Patel,et al.  Balloon-Occluded Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Single-Center US Preliminary Experience. , 2019, Journal of vascular and interventional radiology : JVIR.

[28]  J. Aparicio,et al.  Recommendations for follow-up of colorectal cancer survivors , 2019, Clinical and Translational Oncology.

[29]  C. Catalano,et al.  Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards. , 2019, Journal of vascular and interventional radiology : JVIR.

[30]  Jingxian Shen,et al.  Impact of follow-up interval on patients with hepatocellular carcinoma after curative ablation , 2018, BMC Cancer.

[31]  D. Metz,et al.  Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors , 2018, JAMA oncology.

[32]  S. Young,et al.  Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques , 2018, European Radiology.

[33]  P. Schirmacher,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[34]  L. Brody,et al.  Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology. , 2018, Journal of vascular and interventional radiology : JVIR.

[35]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[36]  A. Gasbarrini,et al.  TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib , 2018, European Radiology.

[37]  P. Schirmacher,et al.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.

[38]  B. Sangro,et al.  Numerical zero‐dimensional hepatic artery hemodynamics model for balloon‐occluded transarterial chemoembolization , 2018, International journal for numerical methods in biomedical engineering.

[39]  B. Guiu,et al.  Liver chemoembolization of hepatocellular carcinoma using TANDEM® microspheres. , 2018, Future oncology.

[40]  J. Levy,et al.  Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[41]  T. Bilhim,et al.  Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 Patients. , 2018, Journal of vascular and interventional radiology : JVIR.

[42]  J. Cercueil,et al.  Intra-arterial idarubicin_lipiodol without embolisation in hepatocellular carcinoma: The LIDA-B phase I trial. , 2018, Journal of hepatology.

[43]  O. Schillaci,et al.  Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma. , 2018, Future oncology.

[44]  O. Yokosuka,et al.  A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization , 2018, Hepatology.

[45]  P. Pereira,et al.  Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies , 2018, OncoTargets and therapy.

[46]  P. Huppert,et al.  Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study , 2017, CardioVascular and Interventional Radiology.

[47]  C. Aliberti,et al.  Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center. , 2017, Journal of vascular and interventional radiology : JVIR.

[48]  C. Catalano,et al.  Single injection dual phase CBCT technique ameliorates results of trans-arterial chemoembolization for hepatocellular cancer. , 2017, Translational gastroenterology and hepatology.

[49]  Ricky A. Sharma,et al.  Locoregional therapies in cholangiocarcinoma. , 2017, Hepatic oncology.

[50]  G. Fiorentini,et al.  Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. , 2017, Future oncology.

[51]  Thomas G. Walker,et al.  Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. , 2017, Journal of vascular and interventional radiology : JVIR.

[52]  Guohong Deng,et al.  Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data , 2017, BMC Cancer.

[53]  L. Brunese,et al.  Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization , 2017, Gastroenterology research and practice.

[54]  P. Pereira,et al.  Transarterial chemoembolization (TACE) with degradable starch microspheres (DSM) in hepatocellular carcinoma (HCC): multi-center results on safety and efficacy , 2017, Oncotarget.

[55]  L. Mir,et al.  Parameters for Stable Water-in-Oil Lipiodol Emulsion for Liver Trans-Arterial Chemo-Eembolization , 2017, CardioVascular and Interventional Radiology.

[56]  J. Geschwind,et al.  Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model , 2017, European Radiology.

[57]  P. Pereira,et al.  Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System , 2017, CardioVascular and Interventional Radiology.

[58]  V. Mazzaferro,et al.  Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma , 2017, World journal of radiology.

[59]  M. Ronot,et al.  Risks factors for severe pain after selective liver transarterial chemoembolization , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[60]  L. Mir,et al.  Stabilization Improves Theranostic Properties of Lipiodol®-Based Emulsion During Liver Trans-arterial Chemo-embolization in a VX2 Rabbit Model , 2017, CardioVascular and Interventional Radiology.

[61]  C. Stave,et al.  The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. , 2017, Journal of vascular and interventional radiology : JVIR.

[62]  P. Pereira,et al.  Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[63]  D. Yellon,et al.  Anthracycline Chemotherapy and Cardiotoxicity , 2017, Cardiovascular Drugs and Therapy.

[64]  K. Hemminki,et al.  The epidemiology of metastases in neuroendocrine tumors , 2016, International journal of cancer.

[65]  R. Finn.  The Role of Liver Biopsy in Hepatocellular Carcinoma. , 2016, Gastroenterology & hepatology.

[66]  T. Pawlik,et al.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection. , 2016, Hepatic oncology.

[67]  T. de Baère,et al.  An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin. , 2016, Journal of vascular and interventional radiology : JVIR.

[68]  W. Oyen,et al.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[69]  J. Geschwind,et al.  Improved Visibility of Metastatic Disease in the Liver During Intra-Arterial Therapy Using Delayed Arterial Phase Cone-Beam CT , 2016, CardioVascular and Interventional Radiology.

[70]  A. Facciorusso,et al.  Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[71]  Yoshinobu Yamamoto,et al.  Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short‐term results , 2016, Hepatology Research.

[72]  O. Matsui,et al.  Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion , 2016, CardioVascular and Interventional Radiology.

[73]  H. Kitagaki,et al.  Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma , 2016, CardioVascular and Interventional Radiology.

[74]  T. Kamoshida,et al.  Selective balloon‐occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super‐selective TACE , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[75]  J. Cercueil,et al.  Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin , 2016, European Radiology.

[76]  Boris Nikolic,et al.  Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria. , 2015, Journal of vascular and interventional radiology : JVIR.

[77]  C. Schraml,et al.  Imaging of HCC—Current State of the Art , 2015, Diagnostics.

[78]  T. Gamblin,et al.  Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[79]  R. Finn.  Treatment of Intermediate-Stage Hepatocellular Carcinoma. , 2015, Gastroenterology & hepatology.

[80]  J. Geschwind,et al.  Delayed-Phase Cone-Beam CT Improves Detectability of Intrahepatic Cholangiocarcinoma During Conventional Transarterial Chemoembolization , 2015, CardioVascular and Interventional Radiology.

[81]  M. Anzidei,et al.  Impact of 3D Rotational Angiography on Liver Embolization Procedures: Review of Technique and Applications , 2015, CardioVascular and Interventional Radiology.

[82]  A. Zhu,et al.  Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma. , 2015, Journal of vascular and interventional radiology : JVIR.

[83]  L. Bonomo,et al.  Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study , 2015, Cardiovascular and Interventional Radiology.

[84]  C. Scoggins,et al.  Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis , 2015, CardioVascular and Interventional Radiology.

[85]  Tomohiro Matsumoto,et al.  Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial microballoon catheter for hepatocellular carcinoma: Technical and safety considerations , 2015, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[86]  Claude B. Sirlin,et al.  LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions , 2015, Hepatology.

[87]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  J. Geschwind,et al.  How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. , 2015, Radiology.

[89]  H. Heinzl,et al.  How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma. , 2014, Journal of hepatology.

[90]  L. Bolondi,et al.  The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series , 2014, Digestive Diseases.

[91]  H. Imamura,et al.  Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization , 2014, International Journal of Clinical Oncology.

[92]  J. Bruix,et al.  Treatment of intermediate-stage hepatocellular carcinoma , 2014, Nature Reviews Clinical Oncology.

[93]  Ashish Kumar,et al.  Treatment Response Evaluation and Follow-up in Hepatocellular Carcinoma. , 2014, Journal of clinical and experimental hepatology.

[94]  K. Kichikawa,et al.  Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. , 2014, The British journal of radiology.

[95]  V. Heinemann,et al.  Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy , 2014, Tumor Biology.

[96]  C. Bartolozzi,et al.  Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma , 2014, British Journal of Cancer.

[97]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[98]  J. Cercueil,et al.  Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial , 2014, Alimentary pharmacology & therapeutics.

[99]  M. Kudo,et al.  Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma , 2014, Hepatology.

[100]  B. Guiu,et al.  Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. , 2013, Critical reviews in oncology/hematology.

[101]  D. Kelekis,et al.  Chemoembolization of Hepatocellular Carcinoma with Hepasphere 30–60 μm. Safety and Efficacy Study , 2013, CardioVascular and Interventional Radiology.

[102]  B. Chauffert,et al.  Lipiodol Trans-arterial Chemoembolization of Hepatocellular Carcinoma with Idarubicin: First Experience , 2013, CardioVascular and Interventional Radiology.

[103]  A. Burroughs,et al.  A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[104]  T. Pawlik,et al.  Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis , 2013, Annals of Surgical Oncology.

[105]  N. Takahashi,et al.  Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure , 2013, CardioVascular and Interventional Radiology.

[106]  Li Xu,et al.  Roles played by chemolipiodolization and embolization in chemoembolization for hepatocellular carcinoma: single-blind, randomized trial. , 2013, Journal of the National Cancer Institute.

[107]  L. Bolondi,et al.  Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension? , 2013, Journal of vascular and interventional radiology : JVIR.

[108]  R. Lencioni,et al.  Chemoembolization of Hepatocellular Carcinoma , 2013, Seminars in Interventional Radiology.

[109]  Qing He,et al.  Transcatheter Arterial Chemoembolization: History for More than 30 Years , 2012, ISRN gastroenterology.

[110]  S. Ahn,et al.  Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma , 2012, Alimentary pharmacology & therapeutics.

[111]  G. Carrafiello,et al.  Quality-Improvement Guidelines for Hepatic Transarterial Chemoembolization , 2012, CardioVascular and Interventional Radiology.

[112]  V. Catalano,et al.  Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. , 2012, Anticancer research.

[113]  N. Kawai,et al.  Prospective Evaluation of Transcatheter Arterial Chemoembolization (TACE) with Multiple Anti-Cancer Drugs (Epirubicin, Cisplatin, Mitomycin C, 5-Fluorouracil) Compared with TACE with Epirubicin for Treatment of Hepatocellular Carcinoma , 2012, CardioVascular and Interventional Radiology.

[114]  R. Omary,et al.  Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors. , 2012, Journal of vascular and interventional radiology : JVIR.

[115]  B. Carr,et al.  Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients , 2011, Medical oncology.

[116]  R. Russell,et al.  Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment , 2011, Current cardiology reviews.

[117]  K. Hausegger,et al.  Patient Safety in Interventional Radiology: A CIRSE IR Checklist , 2011, CardioVascular and Interventional Radiology.

[118]  T. Vogl,et al.  Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations , 2011, CardioVascular and Interventional Radiology.

[119]  S. Terai,et al.  A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial , 2011, Journal of Gastroenterology.

[120]  D. Fraker,et al.  Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol , 2011, Cancer.

[121]  F. Orsi,et al.  Bland Embolization in Patients with Unresectable Hepatocellular Carcinoma Using Precise, Tightly Size-Calibrated, Anti-Inflammatory Microparticles: First Clinical Experience and One-Year Follow-Up , 2010, CardioVascular and Interventional Radiology.

[122]  G. Sotiropoulos,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[123]  M. Makuuchi,et al.  Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. , 2010, AJR. American journal of roentgenology.

[124]  J. Bruix,et al.  Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects , 2010, Seminars in liver disease.

[125]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[126]  M. Okada,et al.  [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)]. , 2009, Gan to kagaku ryoho. Cancer & chemotherapy.

[127]  T. Vogl,et al.  Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study , 2009, CardioVascular and Interventional Radiology.

[128]  Sung W. Shin.  The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma , 2009, Korean journal of radiology.

[129]  Donald L. Miller,et al.  Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. , 2009, Journal of vascular and interventional radiology : JVIR.

[130]  Donald L. Miller,et al.  Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. , 2009, Journal of vascular and interventional radiology : JVIR.

[131]  H. Toyoda,et al.  Impact of a unified CT angiography system on outcome of patients with hepatocellular carcinoma. , 2009, AJR. American journal of roentgenology.

[132]  M. Mack,et al.  Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases , 2009, Cancer Immunology, Immunotherapy.

[133]  I. Kamel,et al.  Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. , 2008, Journal of vascular and interventional radiology : JVIR.

[134]  F. Farinati,et al.  Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma (HCC): The Role of Angiogenesis and Invasiveness , 2008, The American Journal of Gastroenterology.

[135]  Chi-Hung Lin,et al.  Ionic versus nonionic contrast media solvents used with an epirubicin-based agent for transarterial chemoembolization of hepatocellular carcinoma. , 2008, Journal of vascular and interventional radiology : JVIR.

[136]  J. Bruix,et al.  Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. , 2007, Journal of hepatology.

[137]  Kumi Ozaki,et al.  Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil. , 2007, Journal of vascular and interventional radiology : JVIR.

[138]  J. Gaux,et al.  A New Porcine Sponge Material for Temporary Embolization: An Experimental Short-Term Pilot Study in Swine , 2006, CardioVascular and Interventional Radiology.

[139]  T. Katsumori,et al.  The Size of Gelatin Sponge Particles: Differences with Preparation Method , 2006, CardioVascular and Interventional Radiology.

[140]  K. Hong,et al.  New Intra-arterial Drug Delivery System for the Treatment of Liver Cancer: Preclinical Assessment in a Rabbit Model of Liver Cancer , 2006, Clinical Cancer Research.

[141]  P. Tran Ba Huy,et al.  Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. , 2005, Journal of vascular and interventional radiology : JVIR.

[142]  J. Bruix,et al.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.

[143]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[144]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[145]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[146]  P. Tangkijvanich,et al.  Clinical Characteristics and Prognosis of Hepatocellular Carcinoma: Analysis Based on Serum Alpha-fetoprotein Levels , 2000, Journal of clinical gastroenterology.

[147]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.

[148]  M. Al-Ahwal,et al.  Chemoembolization in hepatocellular carcinoma. , 1998, Saudi medical journal.

[149]  K. Ashizawa,et al.  Complications associated with transcatheter arterial embolization for hepatic tumors. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[150]  S. Wallace,et al.  Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. , 1997, Academic radiology.

[151]  M. Kusano,et al.  Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan. , 1997, Seminars in oncology.

[152]  J. Dufaux,et al.  Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. , 1996, Radiology.

[153]  J. Im,et al.  Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma. , 1993, Radiology.

[154]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[155]  Z. Kan,et al.  In Vivo Microscopy of the Liver after Injection of Lipiodol into the Hepatic Artery and Portal Vein in the Rat , 1989, Acta radiologica.

[156]  S Sawada,et al.  Transcatheter oily chemoembolization of hepatocellular carcinoma. , 1989, Radiology.

[157]  M. Makuuchi,et al.  Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. , 1987, Radiology.

[158]  R. Yamada,et al.  Hepatic artery embolization in 120 patients with unresectable hepatoma. , 1983, Radiology.

[159]  R. Yamada,et al.  [Super-selective arterial embolization in unresectable hepatomas (author's transl)]. , 1979, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[160]  D. Planchard,et al.  Interventional radiology: role in the treatment of liver metastases from GEP-NETs , 2015 .

[161]  M. Roček,et al.  Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study , 2010, Annals of Surgical Oncology.

[162]  Seishiro Watanabe,et al.  Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[163]  J. Bruix,et al.  Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.

[164]  J. Dufaux,et al.  Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. , 1995, Radiology.

[165]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.